Answers are grounded in this paper and cite their sources.
Hexahydrocannabinol (HHC) products such as vaping liquids and edibles are widely available in Europe and the US and are frequently represented as “hemp-derived”. Analysis of the products generally shows the presence of two HHC epimers, 9R-hexahydrocannabinol (9R-HHC) and 9S-hexahydrocannabinol (9S-HHC). Varying amounts of unreacted Δ 8 -tetrahydrocannabinol (Δ 8 -THC) and/or Δ 9 -tetrahydrocannabinol (Δ 9 -THC) may also be present. In 2024, we received five jars of a commercial HHC gummy product, which were labeled “50 mg HHC per piece” and stated, “Active Ingredient: Hemp-Derived HHC.” GC-MS analysis identified a total of ten cannabinoids: five parent cannabinoids (9R-HHC, 9S-HHC, Δ 8 -THC, Δ 9 -THC, and iso-hexahydrocannabinol) and five cannabinoid triethylsilyl (TES) derivatives that corresponded to each of the parent cannabinoids. The total content of parent cannabinoids was determined as 36 mg/gummy using HPLC-UV. The total content of cannabinoid TES derivatives was estimated as 6.9 mg/gummy based on both GC-MS and HPLC-UV data. The synthetic processes used in the gummy manufacture are unknown and a definitive explanation for the presence of the TES derivatives has not been formed. To our knowledge, this is the first report of these types of synthetic intermediates being encountered in a commercial HHC product.
No takes yet. Share an insight, caveat, or question.
Laura A. Ciolino (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: